DLL3 targeting chimeric antigen receptors and binding agents
MYPI2025004943A0Undetermined Publication Date: 2020-09-01ALLOGENE THERAPEUTICS INC +1
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- MYPI2025004943
- Authority / Receiving Office
- MY · MY
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2020-02-04
- Filing Date
- 2020-02-27
- Publication Date
- 2020-09-01
Abstract
Provided herein are DLL3 binding agents and chimeric antigen receptors (CARs) comprising a DLL3 binding molecule that specifically binds to DLL3; and immune cells comprising these DLL3-specific CARs, e.g., CAR-T cells. Also provided are methods of making and using DLL3-specific CARs, and immune cells comprising DLL3-specific CARs. FIGURE 1A
Need to check novelty before this filing date? Find Prior Art
